Results 141 to 150 of about 45,441 (213)

<i>TP53</i> Mutations in Mantle Cell Lymphoma: From Backup to Game Changer. [PDF]

J Clin Med
Carazzolo ME, Moioli A, Visco C.
europepmc   +1 more source

Epidemiology, treatment patterns, and survival outcomes of patients with mantle cell lymphoma in Germany: a retrospective analysis of administrative claims data. [PDF]

Ann Hematol
Friedel H, Hennies N, Zschocke J, Hosseini SK, Bölz S, Bocuk D, Wilhelm S, Zaba O, Buske C.   +8 more
europepmc   +1 more source

We are on the right track for mantle cell lymphoma. [PDF]

Br J Haematol
Moioli A, Visco C.
europepmc   +1 more source

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma. [PDF]

Blood Adv
Wang Y, Larson MC, Hwang SR, Villa D, Kugathasan L, Kumar A, Joseph A, Brooks TR, Hill BT, Bond DA, Maddocks KJ, Nizamuddin IA, Kahl BS, Danilov A, Argao C, Ruan J, Ryan CE, Merryman RW, Grover NS, Khan NB, Ouchveridze E, Tun AM, Ayyappan S, Mou E, Pongas GN, Lossos IS, Harris ZI, Munoz JL, Young P, Portell CA, Baidoun F, Alhaj Moustafa M, Reagan PM, Banaszak LG, Pophali PA, Velayati A, Greenwell IB, Gerber D, Jain P, Wang ML, Narkhede MS, Mehta A, Stack AC, Messmer MR, Bhansali RS, Barta SK, Moyo TK, Ghosh N, Kamdar MK, Anna J, Stanisic AV, Karmali R, Maurer MJ, Cerhan JR, Cohen JB, Martin P.   +55 more
europepmc   +1 more source

Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults. [PDF]

Blood Adv
Xie Y, Zhou KS, Li LF, Liang AB, Mei H, Zou DH, Li WY, Jin J, Jin ZM, Jing HM, Yang HY, Chen T, Huang HQ, He PC, Cao JN, Xia Z, Gu YE, Zang YB, Zhou ZS, Tian ZZ, Zhu J, Song YQ.   +21 more
europepmc   +1 more source

Multiple skin tumors in a patient treated with orelabrutinib for mantle-cell lymphoma: Case report. [PDF]

Medicine (Baltimore)
Fu X, Zhang Y, Zeng L, Zhang Q, Fu X.
europepmc   +1 more source

Clinical characteristics and prognostic features of patients with blastoid and pleomorphic variant mantle cell lymphoma: a real-world study in China. [PDF]

Ann Hematol
Huang Y, Zhang X, Lv Y, Wei J, Ye X, Zhang X, Yang C, Zhu Y, Wang J, Xu G, Yang M, Meng H, Xie W, Jin J, Tong H, Yu W.   +15 more
europepmc   +1 more source

Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphoma. [PDF]

Blood Adv
Darnell EP, Gallagher KME, Kanska J, Scarfò I, Balderrama-Gutierrez G, Berger TR, Budka J, Bozym DJ, Huang T, Shen R, Leick MB, Maus MV.   +11 more
europepmc   +1 more source

MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphoma. [PDF]

Blood Adv
Ruan J, Bond DA, Shah B, Allan JN, Rutherford SC, Gribbin C, Chen Z, Bhinder B, Tam W, Rossi D, Xiang J, Hobbie B, Harbhajan M, Sahni TK, Chen GZ, Sigouros M, Inghirami G, Chen-Kiang S, Elemento O, Maddocks K, Leonard JP, Martin P.   +21 more
europepmc   +1 more source

Multiple relapses of mantle cell lymphoma as different extranodal lesions: A case report. [PDF]

Med Int (Lond)
Manabe M, Aohara D, Mukai D, Nanno S, Koh KR.   +4 more
europepmc   +1 more source